Valuation (67%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 21.44 | N/A |
| PEG Ratio (TTM) | -2.69 | N/A |
| P/S Ratio (TTM) | 4.34 | N/A |
| P/B Ratio (TTM) | 5.34 | N/A |
| P/FCF Ratio (TTM) | 14.88 | N/A |
| Price to 5YR AVG Earnings Ratio | 16.75 | N/A |
| Price to 5YR AVG FCF Ratio | 9.47 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.48% | N/A |
| ROE (TTM) | 21.79% | N/A |
| Net Profit Margin (TTM) | 20.33% | N/A |
| ROIC 5YR AVG | 8.47% | N/A |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -4.58% | 194.92% | 151.96% |
| Revenue | 0.59% | -3.76% | -0.43% |
| Net Income | -4.48% | 199.25% | 154.48% |
| Cash Flow | 690.98% | 28.37% | 15.61% |
Health (51%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 10.02 | N/A |
| Quick Ratio (TTM) | 10.02 | N/A |
| D/E Ratio (TTM) | 5.18 | N/A |
| Interest Coverage (TTM) | 1.65 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.46 | N/A |
| LTL to 5YR AVG FCF | 10.42 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.05% | N/A |